Inflation is harmful to nearly all investments, and bonds are no exception. What may seem like a satisfactory return can ...

LENZ Therapeutics' LNZ100 leads presbyopia treatment with superior efficacy and FDA approval likely by Aug. 2025. Learn more ...

As fixed income investors seek clarity beyond surface-level valuation, we look at price transparency measures and how they ...

Today the Board of Directors of the Federal Home Loan Bank of Indianapolis ('FHLBank Indianapolis' or 'Bank') declared its second quarter 2025 dividends on Class B-2 activity-based capital stock and ...

U.S. stock indexes are edging back from their record levels on Tuesday as an incredibly busy week for Wall Street picks up momentum.

The company reported that its second quarter total revenue is expected to exceed $365 million, surpassing its prior guidance of $345 million at the midpoint, and higher than analyst expectations of ...

On Aug. 5, AMD is set to report its fiscal second-quarter earnings, which many anticipate being solid. If revenue comes in ...

With data as of July 28, 2025, we examine if Geospace Technologies Corporation(GEOS) is consistently building momentum based ...

UnitedHealth's stock decline presents a buy opportunity. Explore its long-term growth potential, manageable risks, and strong ...

For stock-market investors over the last three months, even bad news was considered good news. Take falling corporate profits ...

The London Company, an investment management company, released “The London Company Mid Cap Strategy” second quarter 2025 ...

Also Tuesday, the Labor Department said that the number of open jobs in June was 7.4 million, continuing a slow descent and ...